Botanix Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: -0.591x

Botanix Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Botanix Pharmaceuticals Ltd (BOT) has a cash flow conversion efficiency ratio of -0.591x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-48.02 Million ≈ $-33.98 Million USD) by net assets (AU$81.30 Million ≈ $57.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Botanix Pharmaceuticals Ltd (1991–2025)

Cash flow conversion efficiency of Botanix Pharmaceuticals Ltd from 1991 to 2025. This chart illustrates how Botanix Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Botanix Pharmaceuticals Ltd (BOT) share price today for real-time trading data and today's change.

Botanix Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Botanix Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Botanix Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Botanix Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see BOT company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Relpol SA
WAR:RLP
-0.019x
Andira Agro Tbk PT
JK:ANDI
-0.114x
Enry S Island Spa Sb
VI:EIOS
N/A
DATRIX S.P.A.
F:BW6
N/A
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
0.024x
Sphere 3D Corp
NASDAQ:ANY
-0.373x
Domo Activos Socimi SA
MC:DOMO
-0.014x
Polwax SA
WAR:PWX
-0.416x

Annual Cash Flow Conversion Efficiency for Botanix Pharmaceuticals Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Botanix Pharmaceuticals Ltd from 1991 to 2025. Review Botanix Pharmaceuticals Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$81.30 Million
≈ $57.52 Million
AU$-78.58 Million
≈ $-55.60 Million
-0.967x -1193.21%
2024-06-30 AU$108.73 Million
≈ $76.94 Million
AU$-8.13 Million
≈ $-5.75 Million
-0.075x +85.79%
2023-06-30 AU$22.95 Million
≈ $16.24 Million
AU$-12.07 Million
≈ $-8.54 Million
-0.526x +61.66%
2022-06-30 AU$8.15 Million
≈ $5.77 Million
AU$-11.18 Million
≈ $-7.91 Million
-1.372x -861.49%
2021-06-30 AU$20.80 Million
≈ $14.72 Million
AU$-2.97 Million
≈ $-2.10 Million
-0.143x +80.57%
2020-06-30 AU$23.64 Million
≈ $16.72 Million
AU$-17.36 Million
≈ $-12.28 Million
-0.734x +96.56%
2019-06-30 AU$615.22K
≈ $435.30K
AU$-13.14 Million
≈ $-9.30 Million
-21.360x -3410.32%
2018-06-30 AU$16.28 Million
≈ $11.52 Million
AU$-9.91 Million
≈ $-7.01 Million
-0.608x +28.70%
2017-06-30 AU$5.44 Million
≈ $3.85 Million
AU$-4.64 Million
≈ $-3.28 Million
-0.853x -40490.24%
2016-06-30 AU$3.18 Million
≈ $2.25 Million
AU$-6.69K
≈ $-4.73K
-0.002x +99.79%
2015-06-30 AU$1.23 Million
≈ $869.58K
AU$-1.20 Million
≈ $-851.81K
-0.980x -70.31%
2014-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-1.29 Million
≈ $-913.02K
-0.575x -238.34%
2013-06-30 AU$-2.50 Million
≈ $-1.77 Million
AU$-1.04 Million
≈ $-735.77K
0.416x -13.19%
2012-06-30 AU$-2.33 Million
≈ $-1.65 Million
AU$-1.12 Million
≈ $-790.81K
0.479x +54.21%
2011-06-30 AU$-2.23 Million
≈ $-1.58 Million
AU$-692.97K
≈ $-490.32K
0.311x -35.20%
2010-06-30 AU$-1.80 Million
≈ $-1.27 Million
AU$-861.12K
≈ $-609.30K
0.479x +125.99%
2009-06-30 AU$877.74K
≈ $621.06K
AU$-1.62 Million
≈ $-1.15 Million
-1.844x +0.15%
2008-06-30 AU$1.29 Million
≈ $909.99K
AU$-2.38 Million
≈ $-1.68 Million
-1.847x -94.45%
2007-06-30 AU$2.90 Million
≈ $2.05 Million
AU$-2.75 Million
≈ $-1.95 Million
-0.950x +29.94%
2006-06-30 AU$2.22 Million
≈ $1.57 Million
AU$-3.01 Million
≈ $-2.13 Million
-1.356x -64.76%
2005-06-30 AU$3.46 Million
≈ $2.45 Million
AU$-2.84 Million
≈ $-2.01 Million
-0.823x -213.18%
2004-06-30 AU$2.24 Million
≈ $1.59 Million
AU$-589.68K
≈ $-417.24K
-0.263x +9.32%
2002-06-30 AU$4.05 Million
≈ $2.86 Million
AU$-1.17 Million
≈ $-829.68K
-0.290x -395.90%
2001-06-30 AU$5.69 Million
≈ $4.03 Million
AU$-332.70K
≈ $-235.40K
-0.058x +80.44%
2000-06-30 AU$5.15 Million
≈ $3.64 Million
AU$-1.54 Million
≈ $-1.09 Million
-0.299x +45.25%
1999-06-30 AU$8.08 Million
≈ $5.72 Million
AU$-4.41 Million
≈ $-3.12 Million
-0.546x -218.85%
1998-06-30 AU$15.75 Million
≈ $11.15 Million
AU$7.23 Million
≈ $5.12 Million
0.459x +547.35%
1997-06-30 AU$32.05 Million
≈ $22.67 Million
AU$-3.29 Million
≈ $-2.33 Million
-0.103x -8556.45%
1996-06-30 AU$37.91 Million
≈ $26.83 Million
AU$46.00K
≈ $32.55K
0.001x -99.25%
1995-06-30 AU$38.44 Million
≈ $27.20 Million
AU$6.24 Million
≈ $4.42 Million
0.162x +68.58%
1994-06-30 AU$26.04 Million
≈ $18.43 Million
AU$2.51 Million
≈ $1.78 Million
0.096x +25.35%
1993-06-30 AU$18.35 Million
≈ $12.98 Million
AU$1.41 Million
≈ $997.66K
0.077x -39.42%
1992-06-30 AU$11.41 Million
≈ $8.07 Million
AU$1.45 Million
≈ $1.02 Million
0.127x -15.46%
1991-06-30 AU$12.88 Million
≈ $9.11 Million
AU$1.93 Million
≈ $1.37 Million
0.150x --

About Botanix Pharmaceuticals Ltd

AU:BOT Australia Biotechnology
Market Cap
$15.34 Million
AU$21.68 Million AUD
Market Cap Rank
#25747 Global
#1120 in Australia
Share Price
AU$0.01
Change (1 day)
+22.22%
52-Week Range
AU$0.01 - AU$0.14
All Time High
AU$0.52
About

Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment o… Read more